Chris Hindley
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Synthesis and biological activity, Microtubule and mitosis dynamics, Ocular Oncology and Treatments, Cancer Mechanisms and Therapy
Most-Cited Works
- → Cell cycle-regulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis(2011)177 cited
- → A first-in-human, phase 1 study of ASTX029, a dual-mechanism inhibitor of ERK1/2, in relapsed/refractory solid tumors.(2022)1 cited
- → Abstract 3365: Transcriptomics-based stratification of response to MAPK inhibition in vitro better predicts sensitivity to single agent and combination treatment than MAPK genomic alteration status alone(2022)
- → Abstract 1661: Immune modulation by the dual-mechanism ERK inhibitor, ASTX029, in MAPK-activated tumor models(2021)
- → Abstract 2668: Targeting of ERK and HDAC in the treatment of uveal melanoma(2022)
- → Abstract B154: Characterization of a novel ERK1/2 inhibitor, which modulates the phosphorylation and catalytic activity of ERK1/2(2018)
- ATL COM programmer's reference(1998)